The variant B.1.1.7 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the RNA virus causing the pandemic more than a year worldwide, was reported from United Kingdom (UK) in late December 2020. It was reported that mortality increases by 65% and transmissibility increases by 70%, which may result in an increase of reproduction number to 1.13-1.55 from 0.75-0.85. To analyze the global increasing trend of the variant B.1.1.7, we extracted results of B.1.1.7 from GISAID on May 11 and May 12, 2021, and conducted a dose-response regression. It took 47 days to reach 20% and 121 days to reach 50% among the sequence submitted from UK. In Korea, cases of B.1.1.7 have increased since the first report of three cases on December 28, 2020...
Initially recognized of COVID-19 within the world in 2019, the World Health Organization situational...
Background: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
Background: The rise of new SARS-CoV-2 variants worldwide requires global molecular surveillance str...
What is already known about this topic? A more highly transmissible variant of SARS-CoV-2, B.1.1.7, ...
What is already known about this topic? A more highly transmissible variant of SARS-CoV-2, B.1.1.7, ...
UK variant transmission Severe acute respiratory syndrome coronavirus 2 (SARS...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
Background: In December 2020, the United Kingdom (UK) reported a SARS-CoV-2 Variant of Concern (VoC)...
We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 a...
Background The epidemiology of the SARS-CoV-2 B.1.1.7 (or Alpha) variant is insufficiently understoo...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 a...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
As of January of 2021, the highly transmissible B.1.1.7 variant of SARS-CoV-2, which was first ident...
As of January of 2021, the highly transmissible B.1.1.7 variant of SARS-CoV-2, which was first ident...
Initially recognized of COVID-19 within the world in 2019, the World Health Organization situational...
Background: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
Background: The rise of new SARS-CoV-2 variants worldwide requires global molecular surveillance str...
What is already known about this topic? A more highly transmissible variant of SARS-CoV-2, B.1.1.7, ...
What is already known about this topic? A more highly transmissible variant of SARS-CoV-2, B.1.1.7, ...
UK variant transmission Severe acute respiratory syndrome coronavirus 2 (SARS...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
Background: In December 2020, the United Kingdom (UK) reported a SARS-CoV-2 Variant of Concern (VoC)...
We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 a...
Background The epidemiology of the SARS-CoV-2 B.1.1.7 (or Alpha) variant is insufficiently understoo...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 a...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
As of January of 2021, the highly transmissible B.1.1.7 variant of SARS-CoV-2, which was first ident...
As of January of 2021, the highly transmissible B.1.1.7 variant of SARS-CoV-2, which was first ident...
Initially recognized of COVID-19 within the world in 2019, the World Health Organization situational...
Background: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
Background: The rise of new SARS-CoV-2 variants worldwide requires global molecular surveillance str...